Every ASX Healthcare-sector company — what it's trying to cure or help with, and how far along its clinical/commercial pipeline it is.
Rebuilt daily after ASX close — last rebuilt 13 Sep 2026.
⚠ Indication reads each company's own business description (falls back to its general business type when no specific condition is named); Stage reads the most advanced clinical phase mentioned, or an approval/revenue signal — a company-reported read, not an independently verified one. The Phase 1/2/3/Preclinical ladder only applies to drug developers (biotechs and drug manufacturers) — a device, diagnostic or digital-health company follows a different regulatory pathway entirely and shows "—" unless it discloses an explicit trial phase itself.